spironolactone has been researched along with Venous Thromboembolism in 2 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Venous Thromboembolism: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shields, A | 1 |
| Flood, K | 1 |
| Barbieri, JS | 1 |
| Randolph, JF | 1 |
1 review available for spironolactone and Venous Thromboembolism
| Article | Year |
|---|---|
Gender-Affirming Hormone Therapy for Transgender Females.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Estradiol; Estrog | 2018 |
1 other study available for spironolactone and Venous Thromboembolism
| Article | Year |
|---|---|
Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study.
Topics: Acne Vulgaris; Humans; Pulmonary Embolism; Retrospective Studies; Risk Factors; Spironolactone; Veno | 2023 |